Abbonarsi

Liver transplantation for critically ill cirrhotic patients: Results from the French transplant registry - 06/07/22

Doi : 10.1016/j.clinre.2021.101817 
Thierry Artzner a, , Camille Legeai b, Corinne Antoine b, Carine Jasseron b, Baptiste Michard a, François Faitot a, Francis Schneider a, Philippe Bachellier a

Collaborators1

  Liver transplant advisory group, clinical centers and transplant unit surgical and medical supervisors (see the list of participants attached in Acknowledgements).

a Hôpitaux Universitaires de Strasbourg, Strasbourg, France 
b Agence de la Biomédecine, Saint Denis, France 

Corresponding author.

Highlights

Cirrhotic patients transplanted from the ICU have increased post-transplant mortality.
Identifying patients transplanted from the ICU who have poor post-transplant prognosis is essential in order to balance individual and collective utility.
Among cirrhotic patients transplanted from the ICU, four independent factors were associated with poorer prognosis: recipient age, diabetes, intubation prior to transplantation and donor age.
The rate of cirrhotic patients transplanted from the ICU varies greatly among French centers, reflecting diverging approaches to the complex issue of transplanting critically ill cirrhotic patients.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

This study describes the population of cirrhotic patients who were transplanted from the ICU in France, identifying pre-transplant risk factors of post-transplant mortality and describing geographic variations in ICU transplant activity.

Cirrhotic patients transplanted between 2008 and 2018 were included through the national transplant registry. The demographic, clinical and biological characteristics of the patients transplanted from the ICU were compared to cirrhotic patients who were transplanted from home or from the hospital. Risk factors of post-transplant one-year mortality were identified in uni- and multivariable analysis within the population transplanted from the ICU. Funnel plots were used to illustrate center-specific differences in ICU transplant activity.

1,047 cirrhotic patients were transplanted from the ICU during the study period. While the national rate of transplants performed from the ICU was 14.3% the absolute number and the rate of cirrhotic patients transplanted from the ICU varied significantly from one center to another, ranging from 6.6% to 22.8% (p < 0.05). Three recipient-associated independent risk factors one-year post-LT mortality were identified in the population transplanted from the ICU: age > 50 years (HR 1.65, 95%CI 1.16–2.36), p = 0.005), diabetes (HR 1.46, 95%CI 1.07–1.98, p = 0.02) and intubation (HR2.12, 95%CI 1.62-2.78), p < 0.001). Donor age was also independently associated with mortality (HR 1.01, 95%CI 1.01–1.02, p < 0.001). Funnel plots showed significant differences in the proportion of patients transplanted from the ICU and the distribution of risk factors across French transplant centers, especially the inclination to transplant intubated patients.

This study underlines the increased post-transplant mortality among cirrhotic patients transplanted from the ICU. It identifies four clinically pertinent independent risk factors associated with post-transplant mortality in this specific sub-group of transplant candidates. Finally, it illustrates how diverse the landscape of liver transplantation for critically ill cirrhotic patients is across a single country, despite a unified allocation algorithm.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ACLF, BMI, HCC, ICU, LT, MELD


Mappa


© 2021  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 46 - N° 6

Articolo 101817- Giugno 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Risk prediction models for hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy: A meta-analysis
  • Yueli Shen, Jiao Liu, Zhi Han, Weiyun Jiang, Huaizhong Cui, Yunhao Xun
| Articolo seguente Articolo seguente
  • SIB-IMRT combined with apatinib for unresectable hepatocellular carcinoma in patients with poor response to transarterial chemoembolization
  • Xuefen Liu, Jiangping Luo, Longbin Zhang, Fan Yang, Dong Peng

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.